key: cord-0815588-j2jally6
authors: Berry, Colin; Mangion, Kenneth
title: Cardiovascular complications are very uncommon in healthcare workers with mild or asymptomatic COVID-19 infection
date: 2021-05-08
journal: JACC Cardiovasc Imaging
DOI: 10.1016/j.jcmg.2021.04.022
sha: 3ddc75e8d473aa227f39ea7a99b32cc3b21c9a51
doc_id: 815588
cord_uid: j2jally6

[Figure: see text]

Infection with SARS-CoV-2 has potential to be directly injurious to the cardiovascular system (1) and since this is a novel virus, the incidence, nature and severity of cardiovascular involvement in COVID-19 are uncertain. In this article, the COVIDsortium describe a prospective case-control study of cardiovascular abnormalities in healthcare workers six months following mild COVID-19 infection (2) . The study took place in 3 hospitals in London. Of 731 healthcare workers who underwent first wave weekly symptom, PCR and serology assessment during a 4-month period, 157 (21.5%) had evidence of seroconversion. At 6 months after enrolment, 74 seropositive individuals (mean age 37 years, range 18-63, 58% female) and 75 age-, sex-, ethnicity-matched seronegative controls underwent cardiovascular phenotyping using biomarkers and cardiovascular magnetic resonance (CMR) imaging. COVID-19 infection was generally mild; only 1 person was hospitalised and 11 (15%) had been asymptomatic. There were no clinically meaningful differences in the CMR findings between seropositive and seronegative individuals. Specifically, the abnormalities included: reduced left ventricular ejection fraction (n=2, minimum 50%), T1 elevation (n=6), T2 elevation (n=9), and late gadolinium enhancement (n=13, median 1%, max 5% of myocardium). Circulating Some findings merit further comment. 62% of individuals were female. In most series of COVID-19, the sex distribution has been included a higher proportion of male individuals. This J o u r n a l P r e -p r o o f may reflect a selection bias in the current study, or rather naturally reflect the fact that proportionately more women are asymptomatic or have milder forms of illness. Severe, hospitalized SARS-CoV-2 infection affects men to a greater degree (60% male in ISARIC) (5) and the sex distribution is balanced (men: women -(e.g. 4.9 vs 5.1%) in relatively unselected community studies (6, 7) . Furthermore, some of the late gadolinium enhancement (LGE) observed could be due to septal perforator arteries, as the authors mention. A limitation is that cross sectional coronary computed tomography is not available. If these cases were excluded the incidence of LGE would be even lower.

The COVIDsortium study provides as an excellent model to study the residual effects of COVID-19 at approximately 6 months post-infection, with minimal confounding effects of concomitant cardiovascular disease. Thus, the authors conclude that in their population, the maximum prevalence of myocarditis may be <4% at 6 months. This is a reasonably reassuring result drawn from a healthy population however, the sample size limits the precision of this estimate, and the prevalence of cardiovascular abnormalities e.g., myocardial scar, would be expectedly higher in an unbiased community population including individuals from less advantaged socio-economic circumstances e.g., unemployed, and with pre-existing health problems. Nonetheless, healthcare workers represent an important subgroup of the infected population, and dedicated research in this workforce are welcome.

Many of the cardiovascular imaging studies to date have involved selected patient populations, with retrospective recall of patients after discharge from hospital, and an imaging focus that lacked systematic evaluation of participants' disease or health status. Information gaps remain on the prevalence of cardiovascular and multisystem involvement in patients with J o u r n a l P r e -p r o o f symptomatic COVID-19 infection. This question is being prospectively investigated in the Cardiovascular Imaging in COVID-19 (CISCO-19) study (8) . A further knowledge gap is the clinical significance of biochemical evidence of myocardial injury, as reflected by transient or sustained elevation of troponin, which is evident in about 1 in 10 of survivors. This question is being investigated in the UK COVID-HEART study (ISRCTN58667920).

Future studies could target populations of patients who have already had cardiac imaging before COVID-19 infection e.g., the UK Biobank study, however, the protocol did not include contrast imaging hence information on fibrosis, scar and extracellular volume will be lacking.

Other studies that did involve contrast imaging may be susceptible to selection bias. These issues highlight the challenges of undertaking clinical research in the context of an unheralded pandemic.

In conclusion, the COVIDsortium provides welcome, reassuring information that in healthy individuals who experience mild infection with COVID-19, persisting evidence of cardiovascular complications is very uncommon. The results do not support cardiovascular screening in individuals with mild or asymptomatic infection with COVID-19.

J o u r n a l P r e -p r o o f

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

Prospective case-control study of cardiovascular abnormalities six months following mild COVID-19 in healthcare workers

COVID-19: PCR screening of asymptomatic health-care workers at London hospital

Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Resurgence of SARS-CoV-2: detection by community viral surveillance

Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults

The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study